About MTaI
MTaI is an association of research-based medical technology companies who have made remarkable investments by setting up large number of R&D centres and manufacturing plants in India. MTaI represents a wide spectrum of the medical device and equipment industry with global experience in innovation and manufacturing.
All the time stressing on the three hallmarks of healthcare – Quality, Consistency and Patient Safety, we want to be a responsible voice of the industry. We are committed to improving access to affordable and quality healthcare for patients… Read More
MTaI-PwC Whitepaper
Whitepaper on the impact of COVID-19 on the MedTech & Healthcare Industry in India
Click here for details.
Experts Discuss Eldercare At India MedTech Expo 2023, Highlight Focus Areas
On Saturday Eldercare was on focus at the India MedTech Expo 2023 held at the Helipad Exhibition Centre, Gandhinagar in the presence of government stakeholders from various ministries, international diplomats, and industry leaders from MedTech, Hospitals &...
Govt ‘reviews’ order allowing import of pre-owned medical devices after domestic manufacturers object
In a letter to Union health minister, Association of Indian Medical Device Industry had said move would 'increase risk of importing contaminated products & hurt their interests'. The Narendra Modi government is reviewing an earlier order to allow import of some...
Pre-owned medical equipment imports to enhance accessibility: MTaI
Medical Technology Association of India (MTaI) said the import of pre-owned medical equipment can increase accessibility of such equipment for the patients, especially in tier-2 and tier-3 cities Medical Technology Association of India (MTaI) on Tuesday said the...
Industry concerned over lack of discussion on proposed New Drugs, Medical Devices & Cosmetics Bill
Even as the Centre has listed the New Drugs, Medical Devices and Cosmetics Bill, 2023 to be tabled in Parliament during the current session, industry members are apprehensive that the new bill may mean centralisation of licensing and other powers to the Central drug...
Centre to replace Drugs & Cosmetic Act of 1940
The government is ah set to introduce the New Drugs, Medical Devices, and Cosmetics Bill, 2023, during the ongoing Monsoon Session of Parliament to replace the existing 80-year-old Drugs and Cosmetic Act of 1940. The pharmaceutical industry has welcomed the initiative...
Protecting our health data
The Union Cabinet’s recent approval of the Digital Personal Data Protection Bill is a step in the right direction, provided concerns about personal privacy rights are properly addressed and healthcare organisations plan proactively to protect their data The alleged...
